Clinical Trial Update: Tranexamic Acid in Chronic Subdural Hematomas [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update regarding tranexamic acid for chronic subdural hematoma across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Chronic Subdural Hematoma | Phase 2, Phase 3 | Status: UNKNOWN